Analysis And Perspectives

Servier’s Tibsovo has received FDA approval for patients diagnosed with R/R myelodysplastic syndromes that exhibit an IDH1 mutation.

Roche’s Vabysmo secures new FDA nod for retinal vein occlusion treatment, intensifying competition with Regeneron and Bayer’s Eylea.

The Energy-Based Aesthetic Devices market stands at the forefront of the evolving landscape of cosmetic treatments, offering a comprehensive range of solutions for individuals seeking non-invasive and minimally invasive procedures to enhance their appearance. Over the past few years, intense advancements in technol...

Coherus and Junshi received FDA approval for Loqtorzi, marking significant milestone as first-ever nasopharyngeal carcinoma treatment.

The dynamics of the Niemann-Pick Disease Type C treatment market are expected to change owing to the emerging therapies by key companies.

Molecular modeling, a revolutionary branch of science that seeks to understand and manipulate the intricate world of molecules at the atomic and molecular levels, has seen a remarkable transformation in recent years, owing to the growth in technology. The union of computational science, chemistry, and biology has g...

There are several bone sarcoma types, originating from different cells within bone structure and require specialized diagnosis and treatment

Future of gene therapies for hemophilia B treatment holds great promise, offering the potential for a paradigm shift in treatment approaches.

Insulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.

Following two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.